ARCHIVES

NCI Planning To Switch Drug Development Emphasis From Compound To Human Cancer Oriented Strategy

This article is from The Cancer Letter archive.

Vol. 10 No. 41 | October 26, 1984

Download PDF Visit The Full Archive

Related Articles

Interview: “People don’t understand Clinical Trials.

September 5, 1997

NCI CTEP Approved Trials For the Month of February

February 22, 2013

Two-Week Break Balances RT Palliation, Side Effects

February 26, 2010

Also in this 8-page issue: NCI informatics project caBIG will “rapidly accelerate” cancer research, von Eschenbach says.

March 12, 2004

ORI Bars Cleveland Researcher From Federal Funding

March 24, 1995

In Brief: Susumu Tonegawa To Receive Bristol-Myers Award; Mark Green Named Director Of UCSD Cancer Center

March 7, 1986